Vascular health, diabetes, APOE and dementia: The aging, demographics, and memory study

Alzheimer's Research and Therapy

Volumn 2, Issue 3, 2010, Pages

  Llewellyn, David J ^a   Lang, Iain A ^a   Matthews, Fiona E ^b   Plassman, Brenda L ^c   Rogers, Mary Am ^d,e   Morgenstern, Lewis B ^d   Fisher, Gwenith G ^f   Kabeto, Mohammed U ^d   Langa, Kenneth M ^d,e,f  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4;

AGED; AGING; ALLELE; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL ASSESSMENT; DEMENTIA; DEMOGRAPHY; DIABETES MELLITUS; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN INTERACTION; STROKE; UNITED STATES;

EID: 77955520084     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt43     Document Type: Article

References (38)

1. Risk factors for vascular dementia and Alzheimer disease. PB Gorelick, Stroke 2004 35 2620 2622 10.1161/01.STR.0000143318.70292.47 15375299
2. Determinants of vascular dementia in the Cardiovascular Health Cognition Study. LH Kuller OL Lopez WJ Jagust JT Becker ST DeKosky C Lyketsos C Kawas JC Breitner A Fitzpatrick C Dulberg, Neurology 2005 64 1548 1552 10.1212/01.WNL.0000160115.55756.DE 15883315 (Pubitemid 40617690)
3. The Aging, Demographics, and Memory Study: study design and methods. KM Langa BL Plassman RB Wallace AR Herzog SG Heeringa MB Ofstedal JR Burke GG Fisher NH Fultz MD Hurd, et al. Neuroepidemiology 2005 25 181 191 10.1159/000087448 16103729
4. The age-dependent relation of blood pressure to cognitive function and dementia. C Qiu B Winblad L Fratiglioni, Lancet Neurol 2005 4 487 499 10.1016/S1474-4422(05)70141-1 16033691
5. Update on hypertension and Alzheimer's disease. I Skoog D Gustafson, Neurol Res 2006 28 605 611 10.1179/016164106X130506 16945211
6. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. H Lithell L Hansson I Skoog D Elmfeldt A Hofman B Olofsson P Trenkwalder A Zanchetti, J Hypertens 2003 21 875 886 10.1097/00004872-200305000-00011 12714861 (Pubitemid 36677151)
7. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. M Di Bari M Pahor LV Franse RI Shorr JY Wan L Ferrucci GW Somes WB Applegate, Am J Epidemiol 2001 153 72 78 10.1093/aje/153.1.72 11159149
8. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. F Forette ML Seux JA Staessen L Thijs MR Babarskiene S Babeanu A Bossini R Fagard B Gil-Extremera T Laks, et al. Arch Intern Med 2002 162 2046 2052 10.1001/archinte.162.18.2046 12374512
9. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. F Forette ML Seux JA Staessen L Thijs WH Birkenhager MR Babarskiene S Babeanu A Bossini B Gil-Extremera X Girerd T Laks E Lilov V Moisseyev J Tuomilehto H Vanhanen J Webster Y Yodfat R Fagard, Lancet 1998 352 1347 1351 10.1016/S0140-6736(98)03086-4 9802273
10. Risk of dementia in diabetes mellitus: a systematic review. GJ Biessels S Staekenborg E Brunner C Brayne P Scheltens, Lancet Neurol 2006 5 64 74 10.1016/S1474-4422(05)70284-2 16361024 (Pubitemid 41790697)
11. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. GS Watson S Craft, Eur J Pharmacol 2004 490 97 113 10.1016/j.ejphar.2004.02.048 15094077
12. An investigation of the population impact of variation in HbA1c levels in older people in England and Wales: from a population based multi-centre longitudinal study. L Gao FE Matthews LA Sargeant C Brayne, BMC Public Health 2008 8 54 10.1186/1471-2458-8-54 18267013
13. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). E Kokmen JP Whisnant WM O'Fallon CP Chu CM Beard, Neurology 1996 46 154 159 8559366
14. Dementia after stroke: the Framingham Study. CS Ivan S Seshadri A Beiser R Au CS Kase M Kelly-Hayes PA Wolf, Stroke 2004 35 1264 1268 10.1161/01.STR.0000127810.92616.78 15118167
15. Joint effect of stroke and APOE 4 on dementia risk: the Canadian Study of Health and Aging. YP Jin T Ostbye JW Feightner S Di Legge V Hachinski, Neurology 2008 70 9 16 10.1212/01.wnl.0000284609.77385.03 17978275
16. Prevalence of dementia in the United States: the aging, demographics, and memory study. BL Plassman KM Langa GG Fisher SG Heeringa DR Weir MB Ofstedal JR Burke MD Hurd GG Potter WL Rodgers DC Steffens RJ Willis RB Wallace, Neuroepidemiology 2007 29 125 132 10.1159/000109998 17975326
17. Prevalence of cognitive impairment without dementia in the United States. BL Plassman KM Langa GG Fisher SG Heeringa DR Weir MB Ofstedal JR Burke MD Hurd GG Potter WL Rodgers DC Steffens JJ McArdle RJ Willis RB Wallace, Ann Intern Med 2008 148 427 434 18347351
18. Poststroke dementia. D Leys H Henon MA Mackowiak-Cordoliani F Pasquier, Lancet Neurol 2005 4 752 759 10.1016/S1474-4422(05)70221-0 16239182
19. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. (CFAS) NGotMRCCFaASM, Lancet 2001 357 169 175 10.1016/S0140-6736(00)03589-3 11213093
20. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. MN Haan L Shemanski WJ Jagust TA Manolio L Kuller, Jama 1999 282 40 46 10.1001/jama.282.1.40 10404910
21. Genetics of Alzheimer's disease: a centennial review. N Ertekin-Taner, Neurol Clin 2007 25 611 667 v 10.1016/j.ncl.2007.03.009 17659183
22. Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD. C Qiu B Winblad J Fastbom L Fratiglioni, Neurology 2003 61 655 660 12963757
23. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. R Peila BL Rodriguez LJ Launer, Diabetes 2002 51 1256 1262 10.2337/diabetes.51.4.1256 11916953
24. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. A Hofman A Ott MM Breteler ML Bots AJ Slooter F van Harskamp CN van Duijn C Van Broeckhoven DE Grobbee, Lancet 1997 349 151 154 10.1016/S0140-6736(96)09328-2 9111537 (Pubitemid 27039193)
25. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. AJ Slooter MX Tang CM van Duijn Y Stern A Ott K Bell MM Breteler C Van Broeckhoven TK Tatemichi B Tycko A Hofman R Mayeux, Jama 1997 277 818 821 10.1001/jama.277.10.818 9052712
26. An Overview of the Health and Retirement Study. FT Juster R Suzman, The Journal of Human Resources 1995 30 7 56 10.2307/146277
27. Sample Sizes and Response Rates. http://hrsonline.isr.umich.edu/intro/ sho-uinfo.php?hfyle=sample-new-v3&xtyp=2
28. Association AP, Diagnostic and statistical manual of mental disorders Washington, DC: American Psychiatric Assoc 3 1987
29. Association AP, Diagnostic and Statistical Manual of Mental Disorders Washington, DC: American Psychiatric Assoc 4 1994
30. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan, Neurology 1984 34 939 944 6610841
31. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. GC Roman TK Tatemichi T Erkinjuntti JL Cummings JC Masdeu JH Garcia L Amaducci JM Orgogozo A Brun A Hofman DM Moody MD O'Brien T Yamaguchi J Grafman BP Drayer DA Bennett M Fisher J Ogata E Kokmen F Bermejo PA Wolf PB Gorelick KL Bick AK Pajeau MA Bell C DeCarli A Culebras AD Korczyn J Bogousslavsky A Hartmann P Scheinberg, Neurology 1993 43 250 260 8094895
32. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. MM Breteler JJ Claus DE Grobbee A Hofman, Bmj 1994 308 1604 1608 8025427
33. Women, myocardial infarction, and dementia in the very old. MK Aronson WL Ooi H Morgenstern A Hafner D Masur H Crystal WH Frishman D Fisher R Katzman, Neurology 1990 40 1102 1106 2356012
34. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. C Qiu B Winblad A Marengoni I Klarin J Fastbom L Fratiglioni, Arch Intern Med 2006 166 1003 1008 10.1001/archinte.166.9.1003 16682574
35. The Canadian Study of Health and Aging: risk factors for vascular dementia. J Lindsay R Hebert K Rockwood, Stroke 1997 28 526 530 9056606 (Pubitemid 27118372)
36. Heart disease and dementia: a population-based study. F Bursi WA Rocca JM Killian SA Weston DS Knopman SJ Jacobsen VL Roger, Am J Epidemiol 2006 163 135 141 10.1093/aje/kwj025 16293716
37. Influence of myocardial infarction, coronary artery bypass surgery, and stroke on cognitive impairment in late life. H Petrovitch L White KH Masaki GW Ross RD Abbott BL Rodriguez G Lu CM Burchfiel PL Blanchette JD Curb, Am J Cardiol 1998 81 1017 1021 10.1016/S0002-9149(98)00082-4 9576163
38. Neuroimaging and APOE genotype: a systematic qualitative review. N Cherbuin LS Leach H Christensen KJ Anstey, Dement Geriatr Cogn Disord 2007 24 348 362 10.1159/000109150 17911980